- Filed
- May 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.12B sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 678M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $61M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $36M |
| Capex | Q1 2026 · Mar 31, 2026 | $89M |
| Capex | Q1 2026 · Mar 31, 2025 | $57M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $185M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $180M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.94B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.27B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.71B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.69B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $10.5B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.6B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.56B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.32B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $44.49B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $43.34B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.15 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.22 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.15 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.23 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.41B |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.54B |
| Net Income | Q1 2026 · Mar 31, 2026 | $168M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $152M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $616M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $550M |
| Revenue | Q1 2026 · Mar 31, 2026 | $7.35B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $7.19B |